• Home
  • Our Journey
    • About Us
    • Social Impact
    • About Damon Quisenberry
    • About AI System
  • Market Analysis
  • Investment Learning
    • American Equities
    • Capital Funds
    • Bond Securities
    • Currency Markets
    • Virtual Currencies
    • Worldwide Economics
    • Portfolio Strategies
    • Compliance Policies
  • Wealth Building
    • DZA Token
    • Strategy and Vision
    • Weekly Handpicked Stock Collection
  • Digital Learning
    • Learning archive
  • Online Event
    • Online Raffles
    • Voting Campaigns

Investment Learning

Search

Categories

  • American Equities
  • Capital Funds
  • Bond Securities
  • Currency Markets
  • Virtual Currencies
  • Worldwide Economics
  • Portfolio Strategies
  • Compliance Policies

Recent Posts

  • Half of China’s heavy truck sales could be EVs by 2028, CATL says
    May 18, 2025
  • Analysis-Moody’s downgrade intensifies investor worry about US fiscal path
    May 18, 2025
  • Retired artist loses $2M in crypto to Coinbase impersonator
    May 17, 2025
  • April 30, 2025

UK finance minister under investigation for interest registration issue

-- British Finance Minister Rachel Reeves is currently under investigation by the Parliament’s Standards...

Read More
  • April 30, 2025

Saudi central bank sees $21 billion rise in net foreign assets in March

-- The net foreign assets of the Saudi central bank saw an increase of approximately $21 billion in March, according...

Read More
  • April 30, 2025

Russia’s GDP sees 1.4% growth in March, economy ministry reports

-- Russia’s economy witnessed a 1.4% year-on-year increase in its gross domestic product (GDP) in March, following a...

Read More
  • April 30, 2025

Airbus tops Q1 expectations as production set to ramp up

-- Airbus posted stronger-than-expected first-quarter results on Tuesday, boosted by higher revenues and an...

Read More
  • April 30, 2025

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal

By Bhanvi Satija and Mariam Sunny (Reuters) -Novartis has agreed to buy Regulus (NASDAQ:RGLS) Therapeutics for up to $1.7...

Read More
  • April 30, 2025

France stocks higher at close of trade; CAC 40 up 0.50%

– France stocks were higher after the close on Wednesday, as gains in the Utilities, Healthcare and Industrials...

Read More
  • April 30, 2025

Belgium stocks higher at close of trade; BEL 20 up 1.21%

– Belgium stocks were higher after the close on Wednesday, as gains in the Healthcare, Utilities and Telecoms...

Read More
  • April 30, 2025

Pichai pushes back on antitrust remedies, hints at Apple Gemini talks

-- Alphabet Inc (NASDAQ:GOOGL) CEO Sundar Pichai defended Google’s search business in court Wednesday, warning that...

Read More
  • April 30, 2025

Seaport starts coverage of chip stocks, says sell Nvidia, buy Broadcom, AMD

-- Seaport Research started coverage of the semiconductor sector with a cautious view, downgrading Nvidia...

Read More
  • April 30, 2025

Trump tariff whiplash pushes more automakers to scrap profit guidance

By Nick Carey LONDON (Reuters) -Unable to predict the impact of U.S. President Donald Trump’s ever-changing trade war, Stellantis...

Read More
  • ‹
  • 1
  • 2
  • ...
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • ...
  • 1543
  • 1544
  • ›
  • DZ Alliance

    • [email protected]
      • Home
      • Our Journey
      • Market Analysis
      • Investment Learning
      • Wealth Building
      • Digital Learning
      • Online Event
    Copyright © 2025 DZ Alliance. All rights reserved.